Mon, Nov 16WeatherBangor, ME
Maine Lottery
Latest draws loading
Maine News Now

Common blood pressure drug helps more stroke survivors reach critical health target

Common blood pressure drug helps more stroke survivors reach critical health target
100%

Spironolactone Shows Promise in Lowering Blood Pressure for Stroke Survivors

Chicago, Nov. 7, 2026 – A new study presented at the American Heart Association’s annual Scientific Sessions in Chicago indicates that adding the inexpensive heart‑failure medication spironolactone to standard post‑stroke care can noticeably lower blood pressure in survivors whose readings remain high despite treatment.

The randomized REDUCE (Reducing Blood Pressure after Stroke) trial enrolled 160 individuals who had recently experienced a stroke. Participants were divided into two groups: one received spironolactone in addition to their regular blood‑pressure regimen, while the other continued with usual care alone. Researchers monitored home blood‑pressure readings over six months to assess the medication’s effect.

After three months, those taking spironolactone had an average systolic blood pressure (top number) nearly eight points lower than the control group—126 versus 133 mm Hg. A larger proportion of the spironolactone group also reached the American Heart Association’s target of <130/80 mm Hg: 52 % compared with 30 %. Dr. Jordana Cohen, co‑lead of the study and associate professor of medicine and epidemiology at the University of Pennsylvania, highlighted the clinical relevance of these findings, saying, “Lowering blood pressure is the most important step in preventing another stroke, yet many survivors struggle to reach recommended blood‑pressure targets after a stroke.” She added, “When spironolactone was added to post‑stroke care, we saw a meaningful drop in blood pressure that may lower the risk of future strokes and heart attacks.”

Spironolactone, commonly marketed as a “water pill,” works by encouraging the kidneys to excrete excess salt and water, which in turn reduces blood‑pressure load. The drug also increases potassium retention, so patients must have their levels monitored. Dr. Alfred Joshua, a board‑certified emergency physician from California who was not involved in the study, cautioned that the trial did not measure actual stroke or heart‑attack outcomes. “This study measured blood pressure, so whether adding spironolactone leads to fewer repeat strokes is still an open question,” he noted. “We already know that controlling blood pressure lowers the risk of another stroke.”

Joshua also warned of potential side effects. Hyperkalemia—high potassium levels that can develop silently—poses a significant safety concern, especially among those with kidney dysfunction or who are taking other potassium‑sparing medications or supplements. Dizziness from lowered blood pressure is another risk. He advised patients who remain hypertensive after a stroke to bring home readings to their clinician and discuss whether spironolactone might be appropriate.

The REDUCE trial concluded early, enrolling 160 participants instead of the planned 200, and about 15 % of participants had missing readings at the three‑month mark. Those in the spironolactone group were also taking slightly more blood‑pressure medications overall than the control group. Researchers emphasized that while the blood‑pressure benefits are encouraging, larger and longer studies are required to determine whether spironolactone actually reduces the incidence of repeat strokes or heart attacks.

As the medical community continues to seek cost‑effective strategies for secondary prevention after stroke, spironolactone may represent a low‑price, accessible option for patients whose blood pressure remains stubbornly high. Further research will clarify its long‑term benefits and safety profile.

Author

Maine News Now

Maine News Now

Related Stories

Hospital sewers may be breeding grounds for dangerous superbugs, study finds
NATIONALhealth3 days ago

Hospital sewers may be breeding grounds for dangerous superbugs, study finds

Falmouth high schooler publishes women’s health research in medical journal
health3 days ago

Falmouth high schooler publishes women’s health research in medical journal

Health insurance scams to watch for during open enrollment
NATIONALhealth4 days ago

Health insurance scams to watch for during open enrollment